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Role of Exposure Analysis in Solving the Mystery of Balkan Endemic 
Nephropathy
We evaluated the role of exposure analysis in assessing whether ochra-
toxin A or aristolochic acid are the agents responsible for causing Balkan 
endemic nephropathy. We constructed a framework for exposure analy-
sis using the lessons learned from the study of endemic goiter within the 
context of an accepted general model. We used this framework to develop 
an exposure analysis model for Balkan endemic nephropathy, evaluated 
previous findings from the literature on ochratoxin A and aristolochic 
acid in the context of this model, discussed the strength of evidence for 
each, and proposed approaches to address critical outstanding questions. 
The pathway for exposure to ochratoxin A is well defined and there is 
evidence that humans have ingested ochratoxin A. Factors causing dif-
ferential exposure to ochratoxin A and how ochratoxin A is implicated in 
Balkan endemic nephropathy are not defined. Although there is evidence 
of human exposure to aristolochic acid and that its effects are consistent 
with Balkan endemic nephropathy, a pathway for exposure to aristolo-
chic acid has been suggested but not demonstrated. Factors causing dif-
ferential exposure to aristolochic acid are not known. Exposure analysis 
results suggest that neither ochratoxin A nor aristolochic acid can be 
firmly linked to Balkan endemic nephropathy. However, this approach 
suggests future research directions that could provide critical evidence on 
exposure, which when linked with findings from the health sciences, may 
be able to demonstrate the cause of this disease and provide a basis for 
effective public health intervention strategies. One of the key unknowns 
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In the approximately 60 years since Balkan en-
demic nephropathy was first reported, much 
has been learned about the clinical features and 
epidemiology of the disease. While it is general-
ly agreed that at least one environmental toxin 
must be involved, and many have been proposed, 
the responsible agent has not been established. 
New cases continue to be reported today. The 
evaluation of suspected agents has largely focused 
on toxicological aspects, although a limited num-
ber of studies have attempted to evaluate the ex-
tent to which exposure might be consistent with 
the epidemiology of the disease. Several of these 
studies have suggested that certain agents are un-
likely to cause the disease, while consistent but 
inconclusive evidence was found for others (1). 
These preliminary exposure analysis studies, com-
bined with what is currently known about the 
toxicology and epidemiology, provide a basis for 
researchers to focus their attention on the most 
likely possibilities. At this point in time, the two 
potential agents for which reasonable cases can 
be made on the basis of both toxicity and expo-
sure evidence are materials derived from plants 
of the Aristolochia species and mycotoxins, with 
particular emphasis on ochratoxin A (2). These 
two agents were the subject of the recent sympo-
sium from which this paper originates (3). We 
note, however, that other agents or combinations 
of agents remains a possibility.
The underpinning of exposure analysis is 
a model strategy that includes identification 
of the agent(s), the source(s) for the agent, the 
pathway(s) by which the agent gets to humans; 
exposure to the agent; and the disease attrib-
uted to the agent. This basic model is well es-
tablished and described in the environmental 
health literature (4-8). It has been applied ex-
tensively in setting regulatory standards for en-
vironmental pollutants as a part of the risk as-
sessment process.
Building on this general approach, Voice et al 
(1) recently proposed six criteria that can be used 
to evaluate the evidence for proposed agents. 
Two criteria relate to the nephrotoxic and car-
cinogenetic evidence, which are the subject of 
an extensive literature, and are not the subject of 
this paper. From the remaining criteria, we sug-
gest that a convincing case for a proposed agent 
from an exposure analysis perspective should in-
clude the following evidentiary elements:
1. Exposure levels – evidence that exposure 
to this agent occurs in the endemic areas at lev-
els capable of causing both nephrotoxic and car-
cinogenic effects based on the current toxicologi-
cal evidence.
2. Exposure pathway – evidence on how the 
agent moves from an identified point of origin 
or source to the human receptors that is consis-
tent with the known physical, chemical, and bio-
logical properties of the agent and environmental 
conditions and processes in endemic areas.
3. Exposure follows spatial pattern – evidence 
that significantly higher exposure occurs in en-
demic areas than in non-endemic areas and po-
tentially in Balkan endemic nephropathy than 
in non-Balkan endemic nephropathy house-
holds.
4. Explanation for absence of Balkan endemic 
nephropathy in other exposure situations – evi-
dence that either exposure does not occur in oth-
er locations where there is a source of the agent, 
or other factors that substantially mitigate the ex-
tent to which exposure results in disease.
5. Absence of other arguments – absence of 
strong alternative explanations for evidence of-
fered as supportive.
In this article, we first discussed and built 
a framework for exposure analysis in the con-
text of environmentally-linked endemic diseases 
that considered both environmental science and 
health science issues. The case of iodine deficien-
cy and goiter provided a basis for this discussion 
as the underlying environmental and health sci-
ence issues are well understood and the histori-
cal issues associated with the disease have simi-
larities to those of Balkan endemic nephropathy. 
We then applied this approach to evaluating the 
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available exposure evidence for ochratoxin A and 
aristolochic acid in the context of the evidentia-
ry elements outlined above. We concluded dis-
cussions of ochratoxin A and aristolochic acid 
by identifying critical questions that future ex-
posure analysis studies should addressed for these 
two proposed agents.
Exposure analysis (general model and 
endemic goiter case study)
We have taken the formulations of the various 
exposure models of (4-8) and recast them in light 
of the environmental and health sciences (Fig-
ure 1) with exposure as the interface between 
the two sciences. In this context, we define envi-
ronmental science as the application of the prin-
ciples of physical, chemical, biological, and social 
processes to understand the source(s), transport, 
and fate of environmental agents. Dimensions of 
the health sciences include toxicology, epidemi-
ology, diagnosis, pathology, and treatment of the 
disease. We suggest that this model could be use-
ful in understanding Balkan endemic nephropa-
thy, as well as any disease related to exposure to 
a specific environmental agent. Approaching the 
diagram deterministically, the arrows in the en-
vironmental science component follow the flow 
of knowledge from the source to exposure, while 
the arrows in the health science imply the flow of 
knowledge from exposure to establishing the role 
of the agent in causing disease. However, the dia-
gram also suggests the value of taking an inferen-
tial approach, in which observations are used as 
the basis for formulating testable hypotheses for 
those elements that lead to exposure and disease. 
In practice, we often work with fragmentary evi-
dence at multiple points along the diagram and 
must use the available knowledge to postulate 
upstream processes and assess downstream con-
sequences. Using a combination of forward (de-
terministic) and reverse (inferential) approaches, 
the goal is to ultimately complete the full source-
to-disease picture.
To illustrate the various aspects of the expo-
sure analysis model shown in Figure 1, we used 
what is known from many years of study of en-
demic goiter. Simple goiter is an enlargement of 
the thyroid gland when it is unable to meet meta-
bolic demands. The original questions surround-
ing the etiology of endemic goiter in the United 
State and elsewhere in the world were similar to 
those related to Balkan endemic nephropathy. 
For example, the disease is spatially located, relat-
ed to a naturally occurring agent, many hypoth-
eses have been proposed for its etiology, and cases 
Figure 1. Proposed exposure analysis model for environmentally-
linked endemic diseases. Modified from Ott (4,5) and Lioy (6).
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occur today. The development of a complete un-
derstanding of the etiology of endemic goiter is 
one example of how knowledge and approaches 
from both the environmental and the health re-
search communities must be integrated to pro-
duce the full picture. With this knowledge, ef-
fective public health intervention strategies have 
been developed.
Endemic goiter is a very old, global disease (9) 
that was identified in the USA as early as 1797 
(10). Early surveys of the incidence of goiter in 
Native Americans (1908 and 1923) began to re-
veal higher incident rates in the northern por-
tion of the USA, as well as in western moun-
tainous areas (11). The spatial distribution of 
endemic goiter in the USA was better defined 
using health records of draftees of World War 
I and showed that the highest incidence rates 
occurred in the Great Lakes and Pacific North-
west regions of the country, and that there was 
a gradient toward lower rates in the south (12).
Although over 40 hypotheses have been pro-
posed to cause goiter, five have received the great-
est attention; 1) iodine deficiency; 2) hard drink-
ing water; 3) goitrogenic substances (goitrogenic 
factors) in food, water, soils/rocks; 4) pathogens; 
and 5) vitamin A deficiency (12). When iodine 
was discovered in 1811, it was suggested that it 
might cure goiter (13), and by 1820 it was being 
successfully used (14).
By 1927, studies of the spatial relationship 
between the lack of iodine in the environment 
and occurrence of goiter were being reported 
(15). The lack of environmental iodine is caused 
by two factors: 1) certain soil and rock types (16) 
are naturally deficient in iodine and 2) iodine 
has been removed from the environment due to 
leaching by water. Conditions that enhance re-
moval of iodine include those associated with 
glaciation or climate conditions that allow for 
high rainfall (17).
We now put this background information on 
endemic goiter in the context of the framework 
for exposure analysis illustrated in Figure 1. We 
note that environmental agents are diverse and 
include natural and synthetic organic and inor-
ganic chemical, particulate matter, and microbes. 
Some of the toxic organics, such as ochratoxin A, 
can be generated by microbial process. Sources 
for toxic agents can be natural (ultimately soils, 
rocks) or products of human activities such as in-
dustrial wastes. Human activities such as mining 
can also disrupt the environmental and enhance 
the availability of agents. The ultimate source for 
iodine is mineral weathering which adds its con-
centrations to soil and seawater and subsequently 
to food and marine biota, respectively. Except for 
releases of radioactive iodine, there is little dis-
ruption of its environmental behavior due to hu-
man activities (18).
Typically, there are four media in which an 
agent can occur: air, water, soil, and food. For io-
dine, water, soil, and food are important. One 
of the more challenging aspects is often to de-
termine the form of the agent in the media. The 
form of the chemical can significantly change its 
toxicity, mobility, and bioavailability. Methyl 
mercury, for example, is significantly more tox-
ic than elemental mercury. The geochemistry of 
iodine is fairly well established (18). Some of the 
iodine in the environment exists as the free ion-
ic species (iodide, I-), some complexed to oxy-
gen (iodate, IO3-) and some sorbed to soil mate-
rial as an organic complex. The particular form 
of iodine in the environment is in part of a func-
tion of its redox state. Iodide is easily solubilized 
and transported in the environment, and it is the 
dominate form in drinking water and the form 
necessary for health.
It must also be considered that the Earth is a 
dynamic system driving various physical, chemi-
cal, and biological processes. These environmen-
tal processes play a role in the environmental be-
havior of an agent. In terms of environmental 
health issues, knowledge of these processes can 
help to identify areas of risk and therefore under-
stand the spatial patterns of the disease (16). For 
example, it is now recognized that the formation 
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of methyl mercury relies upon the interaction of 
dissolved mercury, organic carbon, and sulfate. 
With this knowledge, preliminary maps have 
been created where environmental conditions 
and processes are conducive for this interaction 
and thus identify potential areas at risk for meth-
yl mercury exposure in the USA (19). Similarly, 
knowledge of the factors influencing the avail-
ability of iodine, as discussed, has made it possi-
ble to predict areas of risk for goiter around the 
globe (20).
The three basic pathways for transport are air, 
water, food. Water (typically groundwater) and 
food are major pathways for iodine.
Human behavioral patterns are a significant 
influence on the fate of environmental contami-
nants leading to exposure. Eating habits and oc-
cupation are examples, but frequently human 
behavior is not well defined. Knowledge of the 
location of soils and rocks that are naturally de-
pleted in iodine or depleted by some environ-
mental process such as running water allows 
prediction of the potential for exposure. Most 
endemic areas are inland. Populations in coastal 
areas who are at risk because of iodine depleted 
soils and water may not contract the disease be-
cause of higher rates of marine fish consumption 
(11,15,21) This serves to illustrate how under-
standing the human behavioral aspects, like envi-
ronmental processes, can help explain the spatial 
distribution of diseases.
The final aspect is the route of entry of the 
agent. Inhalation, ingestion, and dermal contact 
are the major routes and as in the preceding dis-
cussion, ingestion is the route for iodine.
Defining these eight environmental science 
issues establishes that exposure (or lack of expo-
sure) to iodine happens, the conditions under 
which exposure happens (the forward approach), 
and thus, an understanding of the spatial pattern 
of the endemic disease such as goiter.
However, exposure analysis is not complete 
without putting it in the health science context. 
Here we have simplified these aspects to include 
health effects, susceptibility, and exposure indi-
cators (Figure 1). Early work established iodine 
as an essential nutrient required for normal thy-
roid function and that its deficiencies cause goiter. 
Young children (particularly girls) are more suscep-
tible to iodine deficiencies as well as women who 
are pregnant. A low iodine concentration in affect-
ed thyroids was a clear indication of exposure.
In summary, solutions to the endemic goiter 
issue in the United States were based on medical 
science research that showed 1) that iodine defi-
ciency could lead to goiter, 2) evidence of expo-
sure through iodine deficiency in enlarged thy-
roids, and 3) development of well established 
criteria for diagnosis; and on environmental sci-
ence research that showed 1) the forms and 
pathways of iodine in the environment, 2) the 
route of entry through ingestion of water and 
food, and 3) that endemic goiter spatially coin-
cided with soil and rock types naturally deficient 
in iodine or sites where iodine had been removed 
by various environmental processes. The results 
of environmental science and health science re-
search on endemic goiter have established two 
important factors in understanding the exposure, 
how exposure occurs, and the spatial pattern 
of the disease. The strong support for exposure 
from both environmental and health science per-
spectives confirms the role of iodine in the cause 
of endemic goiter. Public health measures such as 
the addition of iodine to diets in iodine deficient 
areas has significantly reduced the magnitude of 
endemic goiter. The history of endemic goiter in 
Croatia is a good example (22). However, goiter 
still remains a global problem, indicating there is 
less than a full understanding of the etiology of 
the disease (23).
Exposure analysis (applications to 
ochratoxin A and aristolochic acid)
Ochratoxin A
Ochratoxin A is a naturally occurring toxic me-
tabolite produced by several molds of the Asper-
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gillus flavus and Penicillium genera, including 
Aspergillus ochraceus (24). The literature on och-
ratoxin A is large and what we present here is 
not intended to be a complete review. Rather, we 
have reviewed the literature to find those papers 
that lead to credible knowledge on the various 
aspects of environmental and health sciences as-
pects leading to exposure. More detailed over-
views of ochratoxin A can be found elsewhere 
(25-27).
Studies have shown ochratoxin A to be neph-
rotoxic (28), genotoxic (29), and immunotox-
ic (30) but uncertainties in its mode of action 
have complicated risk assessments over the past 
10 years (27,30). Although some studies show 
elevated ochratoxin A in hemodialysis patients 
(31), there is a lack of epidemiological evidence 
substantiating its correlation with renal disease 
and cancer risk in human populations at relevant 
exposure levels (27,32). Recent studies have also 
speculated on the role of genetic susceptibility to 
ochratoxin A (28,29).
Known physical factors that influence the 
production of ochratoxin A include tempera-
ture, relative humidity, and insect infestation. 
Chemical factors include the use of fungicides 
and fertilizers (33). Warm temperatures and 
high humidity during grain and other food 
storage favor ochratoxin A formation, and the 
ability to predict the occurrence of ochratox-
in A is developing (34-36). There are some sug-
gestions that ochratoxin A contamination of 
food occurs primarily in pre-harvest periods 
(30). It has also been shown that ochratoxin A 
contamination can take place in the field in cli-
mates that are temperate and humid but such 
conditions are not as well defined as they are 
for storage (37). The climate of southern Eu-
rope favors the growth of Aspergillus species 
over Penicillium (38).
Evidence for widespread exposure to ochra-
toxin A by consumption of contaminated food 
products is unambiguous, with the human dai-
ly intake estimated to range from 0.7 to 4.7 ng/
kg body weight in Western Europe and North 
America (39). Although foodstuff such as grains, 
cheese, and coffee have received much attention, 
there is growing interest in the occurrence of 
ochratoxin A in wine (38,40-42).
There have been many investigations de-
signed to evaluate whether higher exposures oc-
cur, as measured by higher concentrations in 
foodstuffs in endemic villages or in endemic 
households than in selected controls (43-49). 
The results have been mixed, with some studies 
reporting statistically significant differences (47), 
both positive and negative, and others finding 
no significant differences (48). It appears that all 
studies faced a difficult challenge in attempting 
to demonstrate significance, due to the high level 
of variability within the comparative groups, re-
gardless of the classification scheme. This variabil-
ity is such that most studies report high exposure 
levels, relative to risk-based standards, but these 
levels are not inconsistent with what has been re-
ported in many other regions of the world. Oth-
er mycotoxins have also been suggested as possi-
ble causative agents including citrinin, fumonisin 
B1 and B2, zearalenone, and aflatoxin B1 and G1, 
but these have received considerably less research 
attention and the few reports available suggest 
similar variance problems (46,50,51).
Attention has also been devoted to identify-
ing and quantifying biomarkers in Balkan en-
demic nephropathy patients. One group report-
ed two different studies identifying ochratoxin A 
in blood and urine samples of individuals from 
the Vratza endemic region of Bulgaria, but they 
apparently did not find differences between Bal-
kan endemic nephropathy patients and non-pa-
tients (52,53). They also did not find a correla-
tion with the consummation of ochratoxin A 
and recommended against using blood or urine 
levels as markers of exposure. Investigations re-
porting identification of DNA-ochratoxin A ad-
ducts (54,55) have been controversial, and more 
than one research group suggested that true-
adduct formation had not been substantiated 
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(56,57) or that putative adducts did not play a 
role in Balkan endemic nephropathy (58).
From the literature review we can begin to 
address the various issues in the model for the ex-
posure analysis for ochratoxin A. Environmental 
science research has shown the potential for hu-
man exposure to ochratoxin A in both endemic 
and non endemic regions. In the agent box, it is 
well established that ochratoxin A is an organic 
toxin produced from microorganisms and has 
potential risks to human health. Sources for och-
ratoxin A are natural and occur mainly in food 
but can occur in soil. Human activities also in-
fluence the formation of ochratoxin A, for ex-
ample poor grain storage practices. The media of 
occurrence is food and ochratoxin A is known 
to contaminate food that people eat in endemic 
and non endemic areas. Ochratoxin A essentially 
appears in particle-bound form through its asso-
ciation with fungi. A key factor in relating och-
ratoxin A to the distribution of Balkan endemic 
nephropathy is understanding the environmen-
tal process(es) that control its occurrence. As 
noted, efforts are being made along these lines. 
Temperature, humidity, and climate are known 
to influence the production of ochratoxin A but 
not with enough quantification to predict occur-
rence and thus potential differences between en-
demic and non-endemic environments. In addi-
tion, human behavioral patterns that might lead 
to differential exposure to ochratoxin A are not 
clear. Therefore, the reasons why exposure might 
differ between endemic and non endemic areas 
is ill defined. At the present time, the evidence 
does not support ochratoxin A as causative of 
Balkan endemic nephropathy. The critical issue 
is the need to establish a pattern of exposure dif-
ferences between endemic and non-endemic ar-
eas. It does not appear to be as simple as the pres-
ence or absence of ochratoxin A as it is probably 
ubiquitous. Rather, differences might be relat-
ed to either environmental processes and/or to 
human behaviors resulting in exposures that are 
not strictly reflective of environmental levels. It is 
possible that insights can be gained from research 
in other locales, such as that in Tunisia (28,59).
Health science research has shown ochratox-
in A to be a health risk to humans. Results have 
also shown that humans have been exposed to 
ochratoxin A. Whether there is a significant dif-
ference in those exposed between non-endemic 
and endemic areas is unclear. In addition, a lack 
of accepted biomarkers to eliminate the uncer-
tainties in the mechanism of action precludes 
understanding the role of ochratoxin A in caus-
ing Balkan endemic nephropathy. Until these 
questions are answered, health science cannot 
support exposure to ochratoxin A as the cause of 
Balkan endemic nephropathy.
In sum, limitations in both environmental 
and health science elements of exposure to och-
ratoxin A do not allow us to conclude that it is 
linked to Balkan endemic nephropathy. However, 
through this analysis, two questions that need to 
be answered to confirm the role of ochratoxin A 
in Balkan endemic nephropathy are made clear:
1. Given the debate on the influence of och-
ratoxin A on Balkan endemic nephropathy, what 
biomarkers can be identified that clearly establish 
the mechanism by which ochratoxin A causes 
Balkan endemic nephropathy?
2. Given the apparent widespread nature of 
ochratoxin A, what are the factors that cause dif-
ferential exposure to ochratoxin A consistent 
with the disease pattern? For example can differ-
ential exposure be related to differences in food 
or food consumption patterns (42), job exposure 
(60), or a threshold value that is necessary before 
health effects are realized (61,62)
Finally, as noted, ochratoxin A is one of many 
types of mycotoxins and perhaps others need to 
be considered for their role(s) in Balkan endemic 
nephropathy (63).
Aristolochic acid
Evidence of exposure to aristolochic acid in an 
endemic nephropathy patients was first report-
ed by Arlt who detected DNA adducts (as well 
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as “ochratoxin A-related adducts”) in a small 
number of individuals from the Slavonski Brod 
region in Croatia (64). This evidentiary case was 
strengthened by Shibutani et al (65) who veri-
fied and quantified the presence of adducts in 
patients from the same region using 32P-postla-
beling approaches, with confirmation of adduct 
structure by mass spectroscopy. To the best of 
our knowledge, statistically significant differ-
ences between Balkan endemic nephropathy pa-
tients and non-patients from endemic regions 
or residents of similar but non-endemic regions 
have not been reported.
It appears that an exposure pathway for aris-
tolochic acid was first proposed by Kazantizis 
(66) in 1967 who suggested ingestion of bread 
baked from flour that became contaminated as 
a result of the plant growing in wheat fields. Ivic 
(67) refined this hypothesis by reporting a se-
ries of field observations in the South Morava 
endemic region of Serbia in 1969. He indicated 
that Aristolochia clematitis was widespread in the 
region, and frequently but unevenly, co-mingled 
with cultivated wheat. He suggested that it was 
most prevalent in fields with poor soil, less culti-
vation, and more flooding, and those sown with 
unselected wheat grain. Ivic also reports that 
standard harvest practices were to reap the wheat 
with sickles, and bundle it into sheaves, with no 
attempt to separate the Aristolochia. He observed 
a variety of threshing techniques, but claims that 
Aristolochia seeds would not be separated from 
the grain, and would likely contaminate wheat. 
Although no methodology or data are provided, 
Ivic reports observing and counting Aristolochia 
seeds in wheat before milling. Hranjec et al (68) 
collected information on harvesting and milling 
techniques over the past 80 years in the Slavonski 
Brod region in Croatia and conclude that dietary 
exposure via bread made from contaminated 
wheat flour was plausible, especially with older, 
less selective, threshing and milling techniques.
The first apparent attempt to test this hy-
pothesis was reported 36 years later by Hranjec et 
al (69) in 2005. This group conducted a case-con-
trol survey involving three groups in an endem-
ic region of Croatia: EN patients, patients with 
other renal insufficiencies, and non-patients. It 
was reported that EN patients recall observing 
Aristolochia clematitis 20-30 ago more frequent-
ly than other groups, while all three groups recall 
decreases in A. clematitis prevalence in meadows 
and wheat fields, increases in herbicide use, and 
decreases in flooding. It was also reported that a 
greater percentage of individuals in endemic vil-
lages purchased their flour from local sources and 
baked their own bread than those from non-en-
demic villages. Analysis of A. clematitis seeds 
showed the presence of aristolochic acid at high-
er levels than in A. fangchi and A. manchurensis, 
which have been implicated in cases of renal fail-
ure resulting from herbal therapies.
It is clear from both animal and human stud-
ies that Aristolochia species plant material repre-
sents an agent exhibiting nephrotoxic and car-
cinogenic effects similar to those observed in 
Balkan endemic nephropathy. Aristolochic acid 
has been identified as the specific chemical toxin. 
Sources of aristolochic acid are abundant in en-
demic locales, as the plant is frequently found in 
disturbed landscapes, especially at interfaces, such 
as at the edges of agricultural fields, along road-
ways, and in gardens. This observation of preva-
lence does not alone substantiate its role in Bal-
kan endemic nephropathy, however, because it 
is commonly found in many other areas, includ-
ing locales proximate to the endemic areas where 
Balkan endemic nephropathy is not found. The 
overriding question is what causes the spatial pat-
tern of the disease, and that if aristolochic acid is 
responsible, does this result from differences in 
prevalence, or is one of the subsequent elements 
of the model responsible for the exposure dif-
ferences. Attention to date has focused on food, 
specifically wheat flour, as the medium, in which 
aristolochic acid is contained in the form of resid-
ual plant material, such as seeds. Environmental 
process and human behavior evidence is consis-
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tent with this pathway, as Aristolochia clematitis 
is frequently found growing within wheat fields, 
and a plausible argument has been offered that 
aristolochia seeds can be harvested with the 
wheat grain and would not necessarily be separat-
ed during milling such that they are incorporated 
into the flour. The route of entry would thus be 
ingestion of bread made from this flour.
This hypothesis, which was first articulat-
ed by Ivic, is well supported by a set of observa-
tions demonstrating its plausibility. The extent to 
which it has been critically tested is limited, how-
ever. We suggest that to establish wheat flour as 
the likely exposure pathway, a number of ques-
tions need to be addressed in studies designed to 
critically test elements of the hypothesis.
a) Can we verify the presence of aristolochic 
acid in either flour or bread to verify that this is a 
possible pathway?
b) Hranjec et al report differences in recol-
lections of prevalence by residents of endem-
ic and control villages in Croatia (69). Can this 
be substantiated in larger studies, studies in oth-
er endemic areas, and on the basis of more ob-
jective measures such as differences in soil quali-
ty, flooding, and seed purity, as proposed by Ivic 
(67)? Are there other factors not mentioned by 
Ivic, such as herbicide and fertilizer use, that like-
ly affect prevalence and could be objectively mea-
sured?
c) Alternatively, if human behavior differ-
ences are responsible for the observed pattern of 
disease, can we find evidence to support behavior 
patterns that would lead to exposure differenc-
es? These could include considerations of harvest 
schedule, harvesting procedures, threshing and 
milling techniques, amounts and sources of flour 
consumed, and dietary habits.
d) Our recent observations in the endemic 
areas of Croatia and Bulgaria (our unpublished 
data) are not entirely consistent with Ivic’s hy-
pothesis, and these inconsistencies need to be re-
solved. For example, we found that wheat is typi-
cally harvested in mid-summer when Aristolochia 
seeds are immature, contained within a large 
pulpy seed bulb that would be easily separated 
from wheat grain; that combine harvesters have 
been used in some villages for many years and 
that these would easily screen out the immature 
bulbs; and that many villages have had modern 
mechanized mills with sophisticated separation 
technologies available for many years.
We suggest that, given the strength of the ev-
idence linking aristolochic acid exposure to dis-
ease, other potential pathways should also be 
considered. Unfortunately, there is little to be 
found in the literature on the environmental be-
havior of aristolochic acid to guide such an inves-
tigation. A number of possibilities derive from 
our field observations and the more general liter-
ature on Aristolochia sp
a) Could aristolochic acid exposure occur as 
a result of ingestion of Aristolochia clematitis by 
animals and consumption of animal products by 
people? There are previous reports of kidney dis-
ease in horses (70,71) but anecdotal comments 
by residents in our field investigation suggest that 
grazing animals avoid consuming this plant.
b) Could aristolochic acid, a by-product or 
related agent, be exuded by Aristolochia plants 
and taken up by food plants? The foods most 
likely would be those where Aristolochia grows 
in close proximity, which in our observations, in-
clude wheat and grapes. We are not aware of ex-
perimentally-determined parameters reflective of 
environmental mobility, but it is estimated that 
aristolochic acid is slightly soluble, and parti-
tions very little to soil at pH 6 or above (72). This 
suggests that release and uptake by other plants 
could occur.
c) Could aristolochic acid exposure occur 
via dermal contact by field workers? We note an 
anecdotal report from Bulgaria indicating that 
nearly all of the workers on one particular farm 
developed nephritis.
d) It has apparently been a long-standing 
practice in this region to burn the wheat fields 
following the harvest. Could aristolochic acid ex-
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posure to field workers occur via the smoke, for 
example by inhalation, ingestion, or dermal con-
tact?
e) Oral ingestion as a medicinal herb remains 
a possibility. There is a long history throughout 
the world of using Aristolochia sp for various pur-
poses (73) and there are a few reports of such use 
in endemic areas (68,74).
Summary
Exposure analysis attempts to relate an environ-
mental agent (eg, chemical, microbe) to the cause 
of a particular disease through the environmen-
tal sciences that examine how and if exposure can 
occur, and health sciences that examine evidence 
of exposure having taken place. A particular chal-
lenge for the environmental sciences in the case 
of endemic diseases such as Balkan endemic ne-
phropathy is to account for the spatial pattern 
(ie, factors that cause differential exposure). We 
have discussed how exposure analysis confirms 
the role of iodine in endemic goiter.
Exposure analysis showed that neither ochra-
toxin A or aristolochic acid could be confirmed 
to cause Balkan endemic nephropathy. The anal-
ysis did reveal environmental and health scienc-
es aspects that need study before the roles of ei-
ther agent can be fully understood. For both 
agents, how differential exposure can occur is 
not known. Further, showing how ochratoxin 
A is involved in the diseases through biomarkers 
(health sciences) and how exposure to aristoloch-
ic acid happens through understanding process 
(environmental sciences) is needed.
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